News

Why are more than 300 people in the US still dying from COVID every week?
Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
FDA plans to limit COVID shots to those over 65 or with high-risk conditions
Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC ...
BioSpace4d
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...
Covid vaccine rollout for healthy kids and adults is likely delayed by a new FDA rule
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
Gulf News6d
Covid test, vaccine maker stocks jump as cases surge in Asia
Shares of Covid test kit and drug makers in Asia rose following ... those in facilities to get inoculated with the JN.1 shot from Pfizer Inc. and BioNTech SE. “Covid-19 has been increasingly ...
US limits COVID boosters to over-65s or those at high risk
The United States will limit COVID-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...